The $1.7 Trillion Opportunity
The global pharmaceutical market is massive—but drug development remains slow and expensive. Dynamic modelling changes the game.
Cryptic Pockets
Reveal binding sites only visible in transient states
Resistance
Model how mutations affect drug binding dynamics
Biologics
Engineer antibodies with specific binding properties

Figure: MD-based refinement revealing cryptic binding sites
Synthetic Biology & Enzymes
Beyond health, this work fuels innovation in sustainable biotechnology. By rationally designing novel enzymes, we create more efficient biocatalysts for industrial processes.
Replace harsh chemicals with biological catalysts
Optimize enzymes for industrial-scale reactions
Real-World Applications
Cancer Therapeutics
Design inhibitors targeting mutant kinases
Antibiotic Resistance
Predict resistance mutations before they emerge
Enzyme Engineering
Create biocatalysts for sustainable manufacturing